Soliris (Eculizumab) 300 Mg In India

  • Brand Name: SOLIRIS
  • Active Ingredient: Eculizumab
  • Dosage Form: 300 mg single-use vials containing 30 mL of 10 mg/ml.
    Manufacturer Name: Alexion Pharma, Inc.
Get Price


Soliris (Eculizumab) Uses

Eculizumab specifically is a complement inhibitor used for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH) to reduce hemolysis. It is also used for the treatment of patients with atypical hemolytic uremic syndrome (aHUS) to inhibit the complement-mediated thrombotic microangiopathy.

Dosage: The recommended eculizumab dose will be administered by your doctor or other healthcare professional by infusing a dilution of the eculizumab vial from a drip bag through a tube directly into one of your veins. It is recommended that the beginning of your treatments, called the initial phase, will extend over 4 weeks, followed by a maintenance phase.

Side Effects: The most commonly reported eculizumab side effects are: PNH: nasopharyngitis, headache, back pain, and nausea. aHUS: hypertension, upper respiratory tract infection, urinary tract infection, diarrhea, headache, anemia, vomiting, nausea, and leukopenia.

Warnings and Precautions:

  • The soliris injection is contraindicated in patients with unresolved serious Neisseria meningitidis infection.
  • Discontinue eculizumab 300 mg in patients who are being treated for the serious meningococcal infections.
  • Caution should be used when administering eculizumab to patients with any other systemic infection.
  • Monitor patients after discontinuing eculizumab injection for at least 8 weeks for detecting hemolysis.
  • Caution should be exercised when this medication is administered to a nursing woman.
  • The soliris 300 mg injection should be used during pregnancy only in case the potential benefit justifies the potential risk to the fetus.

More info

Storage: Store the vials of Eculizumab in the original carton until the time of use under refrigerated conditions at 2°C to 8°C (36°F to 46°F) and protected from light. Do not use beyond the expiration date stamped on the carton. Availability in India: The Indian Pharma helps connect buyers with suppliers who can ship the SOLIRIS at the global level as per the needs of buyer’s. The Indian Pharma provides guarantee of quality as well as delivery for the SOLIRIS Injections. Buying Procedure: In order to buy SOLIRIS, you can contact us at our Toll-free number 1800 889 1064 or on WhatsApp +919310090915 or an Email to us at: along with the legitimate ID Proof, standard Prescription and Medical Reports. Conclusion: Current findings suggest that the Eculizumab improves SR and ORR in patients with PNH and aHUS. Eculizumab treatment is well tolerated.


What is SOLIRIS? SOLIRIS (active substance eculizumab) belongs to a class of drugs named monoclonal antibodies. It is introduced to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). How is SOLIRIS supplied? SOLIRIS is supplied as 300 mg single-use vials containing 30mL of 10 mg/ml for intravenous administration. In how many countries SOLIRIS is approved for marketing? SOLIRIS is available/approved in the USA and Europe. We can help you to access it in India. How can I get SOLIRIS in India? SOLIRIS is a prescription-only drug and is not approved for marketing in India. The Indian Pharma (IP) is a consulting pharmaceutical company which assists Patients in accessing medicines in India. The Indian Pharma facilitates such access only against valid prescriptions in conformity with all local laws and regulations. Patients/ Clinicians / Researchers can contact IP at +91-120-4080562 or write to at – We facilitate by-
  • Helping in documentation to import the medicine for personal use.
  • Finding Genuine and reliable sources in the USA, Europe and Japan.
  • Ensuring 100% transparency.
SOLIRIS can be shipped to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Jaipur, Lucknow, Cochin and Pune and other cities in India. The Indian Pharma can facilitate the supply of SOLIRIS (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement. The Indian Pharma does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturers or licensees. Can I get SOLIRIS even if I am not based in India? Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. The Indian Pharma (IP) can help patients in accessing/importing SOLIRIS, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country. Send your enquiry to find- SOLIRIS in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
  • SOLIRIS in the United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
  • SOLIRIS in North America – Mexico.
  • SOLIRIS in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
  • SOLIRIS in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
  • SOLIRIS in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
  • SOLIRIS in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
  • SOLIRIS in Australia and New Zealand.
How do I contact The Indian Pharma? You can use a different channel to contact The Indian Pharma (TIP) Tele & Mobile: You can reach us on +91 9310090915 or +91-120-4080562. Email: We can also address your enquiries if sent directly to We will respond within 24 hours along with eculizumab price & procurement details after receiving your mail. Please mention detailed enquiry, your contact number with ISD code while sending your mail. We will respond within 1 working day after receiving your query form.


What information do you need to help patient in assisting documentation for SOLIRIS import for personal use?

We will require the following documents to help in documentation for Named-Patient import

  • Doctor’s Prescription – We would require prescription from Registered Medical Practitioner Stating Product name, dosage, duration of treatment and diagnosis
  • Patient’s Medical history – We would require all test reports and Medical reports of the patient for last 3 months.
  • Patient’s Identity card – We will require scan copy of Patient’s identity card and proof of residence to initiate documentation process. You can use copy of Passport, Driving License, Employee ID card or any Photo ID document as your Identity card.